CLINICAL_TRIALS
trial_result
· 2016-05-05
Clinical Trial Update: A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients [Phase 1]
Summary
A Phase 1 study evaluating the effects of aflibercept on QTc interval in cancer patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Cancer | Phase 1 | Status: COMPLETED